Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Piperidines | 5 | 2002 | 73 | 0.550 |
Why?
|
| Antiemetics | 6 | 2002 | 97 | 0.520 |
Why?
|
| Analgesics, Opioid | 6 | 2002 | 532 | 0.500 |
Why?
|
| Anesthesiology | 2 | 2023 | 40 | 0.380 |
Why?
|
| Alfentanil | 2 | 2002 | 4 | 0.280 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2002 | 13 | 0.270 |
Why?
|
| Imidazoles | 3 | 1992 | 82 | 0.250 |
Why?
|
| Nausea | 3 | 1998 | 111 | 0.240 |
Why?
|
| Morphine | 2 | 2000 | 61 | 0.240 |
Why?
|
| Vomiting | 3 | 1998 | 139 | 0.230 |
Why?
|
| Malignant Hyperthermia | 3 | 1990 | 5 | 0.230 |
Why?
|
| Anesthetics, Intravenous | 2 | 2002 | 25 | 0.220 |
Why?
|
| Propofol | 2 | 2002 | 21 | 0.220 |
Why?
|
| Liver Diseases | 2 | 1996 | 157 | 0.210 |
Why?
|
| Ondansetron | 4 | 1998 | 33 | 0.210 |
Why?
|
| Postoperative Complications | 4 | 1998 | 1336 | 0.200 |
Why?
|
| Droperidol | 1 | 2002 | 1 | 0.190 |
Why?
|
| Drug Labeling | 1 | 2002 | 24 | 0.190 |
Why?
|
| Nitrofurantoin | 4 | 1985 | 10 | 0.190 |
Why?
|
| Anesthetics, Combined | 1 | 2002 | 3 | 0.180 |
Why?
|
| Anesthesia, Intravenous | 1 | 2002 | 13 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 216 | 0.150 |
Why?
|
| Serotonin Antagonists | 1 | 1998 | 31 | 0.140 |
Why?
|
| Respiration | 2 | 2000 | 97 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2002 | 859 | 0.130 |
Why?
|
| Double-Blind Method | 6 | 2002 | 747 | 0.120 |
Why?
|
| Esterases | 1 | 1995 | 13 | 0.110 |
Why?
|
| Injections, Intravenous | 5 | 2000 | 160 | 0.110 |
Why?
|
| Anesthesia, General | 3 | 2002 | 47 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 197 | 0.100 |
Why?
|
| Premedication | 2 | 1993 | 20 | 0.100 |
Why?
|
| Adult | 14 | 2002 | 17571 | 0.100 |
Why?
|
| Erythrocytes | 2 | 1985 | 147 | 0.100 |
Why?
|
| Butorphanol | 1 | 1991 | 4 | 0.090 |
Why?
|
| Midazolam | 1 | 1991 | 12 | 0.090 |
Why?
|
| Humans | 25 | 2023 | 65831 | 0.080 |
Why?
|
| Analgesia, Epidural | 1 | 1991 | 22 | 0.080 |
Why?
|
| Glutathione Reductase | 2 | 1981 | 5 | 0.080 |
Why?
|
| Oxazoles | 1 | 1990 | 10 | 0.080 |
Why?
|
| Muscle Relaxants, Central | 1 | 1990 | 12 | 0.080 |
Why?
|
| Ketamine | 1 | 1989 | 40 | 0.070 |
Why?
|
| Amides | 1 | 1989 | 61 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 1989 | 73 | 0.070 |
Why?
|
| Female | 13 | 2002 | 34419 | 0.070 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2008 | 2 | 0.070 |
Why?
|
| Drug Interactions | 2 | 2002 | 126 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 60 | 0.070 |
Why?
|
| Safety Management | 1 | 2008 | 139 | 0.060 |
Why?
|
| Male | 10 | 2002 | 31403 | 0.060 |
Why?
|
| Middle Aged | 7 | 2002 | 18495 | 0.060 |
Why?
|
| Superoxides | 2 | 1982 | 73 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2008 | 488 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 1991 | 922 | 0.050 |
Why?
|
| Academic Performance | 1 | 2023 | 7 | 0.050 |
Why?
|
| Oxygen | 2 | 1982 | 323 | 0.050 |
Why?
|
| Safety | 4 | 2008 | 142 | 0.050 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 56 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2002 | 92 | 0.050 |
Why?
|
| Arthroscopy | 1 | 2002 | 34 | 0.050 |
Why?
|
| Oxyhemoglobins | 1 | 1982 | 9 | 0.040 |
Why?
|
| Shoulder Joint | 1 | 2002 | 33 | 0.040 |
Why?
|
| Aged | 5 | 2002 | 15143 | 0.040 |
Why?
|
| Daunorubicin | 1 | 1981 | 7 | 0.040 |
Why?
|
| Morphine Derivatives | 1 | 2000 | 1 | 0.040 |
Why?
|
| Pupil | 1 | 2000 | 9 | 0.040 |
Why?
|
| Doxorubicin | 1 | 1981 | 98 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 2497 | 0.040 |
Why?
|
| Quinolizines | 1 | 2000 | 8 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2000 | 161 | 0.040 |
Why?
|
| Knee Joint | 1 | 2002 | 312 | 0.040 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2000 | 49 | 0.040 |
Why?
|
| Indoles | 1 | 2000 | 112 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 1989 | 170 | 0.040 |
Why?
|
| Swine | 2 | 1990 | 398 | 0.040 |
Why?
|
| Mental Processes | 1 | 1998 | 18 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1998 | 66 | 0.030 |
Why?
|
| Adolescent | 3 | 1998 | 6367 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1997 | 68 | 0.030 |
Why?
|
| Electroencephalography | 1 | 1998 | 156 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1998 | 344 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 849 | 0.030 |
Why?
|
| Nitrous Oxide | 1 | 1995 | 7 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 1993 | 193 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 1998 | 5682 | 0.030 |
Why?
|
| Pilot Projects | 2 | 1995 | 1029 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2000 | 3339 | 0.030 |
Why?
|
| Methemoglobin | 3 | 1985 | 5 | 0.030 |
Why?
|
| Glutathione | 2 | 1985 | 55 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1985 | 491 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1996 | 1146 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1992 | 43 | 0.020 |
Why?
|
| Abdomen | 1 | 1992 | 97 | 0.020 |
Why?
|
| Fatigue | 1 | 1992 | 114 | 0.020 |
Why?
|
| Animals | 5 | 1990 | 21491 | 0.020 |
Why?
|
| Preanesthetic Medication | 1 | 1991 | 2 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 1991 | 6 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 200 | 0.020 |
Why?
|
| Halothane | 1 | 1990 | 3 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1991 | 139 | 0.020 |
Why?
|
| Affect | 1 | 1991 | 132 | 0.020 |
Why?
|
| Memory | 1 | 1991 | 124 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1989 | 72 | 0.020 |
Why?
|
| United States | 1 | 2002 | 8189 | 0.020 |
Why?
|
| Benzene | 2 | 1979 | 6 | 0.020 |
Why?
|
| Placebos | 2 | 2000 | 73 | 0.020 |
Why?
|
| Data Collection | 1 | 2008 | 384 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 1985 | 83 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1985 | 111 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1985 | 301 | 0.010 |
Why?
|
| Hemolysis | 1 | 1982 | 41 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1982 | 30 | 0.010 |
Why?
|
| Nitriles | 1 | 1982 | 82 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1982 | 25 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1982 | 30 | 0.010 |
Why?
|
| Catalase | 1 | 1982 | 22 | 0.010 |
Why?
|
| Horses | 1 | 1982 | 53 | 0.010 |
Why?
|
| Cattle | 1 | 1982 | 320 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1982 | 328 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1982 | 223 | 0.010 |
Why?
|
| Nitro Compounds | 1 | 1980 | 15 | 0.010 |
Why?
|
| Kinetics | 1 | 1982 | 758 | 0.010 |
Why?
|
| Toluene | 1 | 1979 | 8 | 0.010 |
Why?
|
| Remission Induction | 1 | 2000 | 149 | 0.010 |
Why?
|
| Myocardium | 1 | 1982 | 302 | 0.010 |
Why?
|
| Species Specificity | 1 | 1980 | 344 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2000 | 413 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1980 | 357 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1979 | 136 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 606 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 579 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 746 | 0.010 |
Why?
|
| Liver | 1 | 1982 | 875 | 0.010 |
Why?
|
| Sex Factors | 1 | 2000 | 995 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1274 | 0.010 |
Why?
|
| Rats | 1 | 1980 | 2005 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1997 | 191 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1980 | 573 | 0.010 |
Why?
|
| Dizziness | 1 | 1993 | 19 | 0.010 |
Why?
|
| Headache | 1 | 1993 | 58 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1979 | 96 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2000 | 5831 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1979 | 279 | 0.000 |
Why?
|
| Time Factors | 1 | 1993 | 3777 | 0.000 |
Why?
|
| Chemistry | 1 | 1979 | 31 | 0.000 |
Why?
|
| Drug Stability | 1 | 1979 | 145 | 0.000 |
Why?
|
| Cyanides | 1 | 1978 | 3 | 0.000 |
Why?
|
| Fourier Analysis | 1 | 1978 | 31 | 0.000 |
Why?
|
| Chemistry, Physical | 1 | 1978 | 46 | 0.000 |
Why?
|
| Temperature | 1 | 1979 | 317 | 0.000 |
Why?
|
| Heme | 1 | 1978 | 30 | 0.000 |
Why?
|
| Fluorides | 1 | 1978 | 29 | 0.000 |
Why?
|